These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27737842)

  • 1. The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model.
    Sadatsafavi M; Sin DD; Zafari Z; Criner G; Connett JE; Lazarus S; Han M; Martinez F; Albert R
    Am J Epidemiol; 2016 Nov; 184(9):681-689. PubMed ID: 27737842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
    Uzun S; Djamin RS; Kluytmans JA; Mulder PG; van't Veer NE; Ermens AA; Pelle AJ; Hoogsteden HC; Aerts JG; van der Eerden MM
    Lancet Respir Med; 2014 May; 2(5):361-8. PubMed ID: 24746000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology.
    Sadatsafavi M; Xie H; Etminan M; Johnson K; FitzGerald JM;
    PLoS One; 2018; 13(1):e0191243. PubMed ID: 29351331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.
    Ra SW; Sze MA; Lee EC; Tam S; Oh Y; Fishbane N; Criner GJ; Woodruff PG; Lazarus SC; Albert R; Connett JE; Han MK; Martinez FJ; Aaron SD; Reed RM; Man SFP; Sin DD;
    Respir Res; 2017 May; 18(1):109. PubMed ID: 28558695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials.
    Król A; Palmér R; Rondeau V; Rennard S; Eriksson UG; Jauhiainen A
    Respir Res; 2020 Jun; 21(1):158. PubMed ID: 32571311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors.
    So JY; Zhao H; Voelker H; Reed RM; Sin D; Marchetti N; Criner GJ
    Ann Am Thorac Soc; 2018 Nov; 15(11):1296-1303. PubMed ID: 30063372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly.
    Taylor SP; Sellers E; Taylor BT
    Am J Med; 2015 Dec; 128(12):1362.e1-6. PubMed ID: 26291905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Vermeersch K; Gabrovska M; Deslypere G; Demedts IK; Slabbynck H; Aumann J; Ninane V; Verleden GM; Troosters T; Bogaerts K; Brusselle GG; Janssens W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():687-96. PubMed ID: 27099485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
    Naderi N; Assayag D; Mostafavi-Pour-Manshadi SM; Kaddaha Z; Joubert A; Ouellet I; Drouin I; Li PZ; Bourbeau J
    Respir Med; 2018 May; 138():129-136. PubMed ID: 29724384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy.
    Blasi F; Bonardi D; Aliberti S; Tarsia P; Confalonieri M; Amir O; Carone M; Di Marco F; Centanni S; Guffanti E
    Pulm Pharmacol Ther; 2010 Jun; 23(3):200-7. PubMed ID: 20025989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study.
    Wetherbee EE; Niewoehner DE; Sisson JH; Lindberg SM; Connett JE; Kunisaki KM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1363-70. PubMed ID: 26229455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study.
    Boggon R; Hubbard R; Smeeth L; Gulliford M; Cassell J; Eaton S; Pirmohamed M; van Staa TP
    BMC Pulm Med; 2013 May; 13():32. PubMed ID: 23724907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.
    Han MK; Tayob N; Murray S; Dransfield MT; Washko G; Scanlon PD; Criner GJ; Casaburi R; Connett J; Lazarus SC; Albert R; Woodruff P; Martinez FJ
    Am J Respir Crit Care Med; 2014 Jun; 189(12):1503-8. PubMed ID: 24779680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
    Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial.
    Vermeersch K; Belmans A; Bogaerts K; Gyselinck I; Cardinaels N; Gabrovska M; Aumann J; Demedts IK; Corhay JL; Marchand E; Slabbynck H; Haenebalcke C; Vermeersch S; Verleden GM; Troosters T; Ninane V; Brusselle GG; Janssens W;
    Respir Res; 2019 Oct; 20(1):237. PubMed ID: 31665017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review.
    Puhan MA; Vollenweider D; Latshang T; Steurer J; Steurer-Stey C
    Respir Res; 2007 Apr; 8(1):30. PubMed ID: 17407610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin in the treatment of patients with exacerbation of chronic obstructive pulmonary disease.
    Płusa T
    Pol Merkur Lekarski; 2020 Feb; 48(283):65-68. PubMed ID: 32218410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.